男性、当前吸烟和既往肠切除是克罗恩病术后内镜复发的危险因素:一项前瞻性队列研究结果
这项前瞻性全国性研究在法国九家学术中心纳入289例克罗恩病回盲部切除患者,其中225例在术后1年内接受内镜评估。术后内镜复发(Rutgeerts评分≥i2)见于107例(47%)。多因素分析显示男性、手术时当前吸烟和既往肠切除与内镜复发风险升高相关,而术后抗TNF治疗与风险降低相关。
要点
- 男性、手术时当前吸烟和既往肠切除与克罗恩病术后内镜复发风险升高独立相关。
- 术后抗TNF治疗与克罗恩病术后内镜复发风险降低相关。
- 术后6-12个月内镜复查可评估复发,Rutgeerts评分≥i2定义为内镜复发。
核心结论
- 男性、手术时当前吸烟和既往肠切除与克罗恩病术后内镜复发风险升高相关,而术后抗TNF治疗与风险降低相关。
研究设计与样本
- REMIND研究组于2010年9月至2017年在法国九家学术中心开展的前瞻性全国性研究。
- 共纳入289例克罗恩病回盲部切除患者,其中225例(78%)在术后1年内接受内镜评估(104例男性/121例女性)。
主要发现
- 225例接受内镜评估的患者中,107例(47%)发生内镜复发(Rutgeerts评分≥i2)。
- 多因素分析中,男性与内镜复发风险升高相关(OR=2.48,95%CI 1.40-4.46)。
- 手术时当前吸烟与内镜复发风险升高相关(OR=2.65,95%CI 1.44-4.97)。
- 既往肠切除与内镜复发风险升高相关(OR=3.03,95%CI 1.36-7.12)。
- 术后抗TNF治疗与内镜复发风险降低相关(OR=0.50,95%CI 0.25-0.96)。
关键数值与推荐
- 内镜复发定义为Rutgeerts评分≥i2。
- 225例患者平均年龄35岁(标准差12.2),平均病程8.8年(标准差8.9)。
- 70例(32%)患者手术时当前吸烟;142例(63%)患者术前接受过至少一种抗TNF治疗。
- 术后40例(18%)患者接受硫嘌呤类药物治疗,66例(29%)患者接受抗TNF药物治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After ileocaecal resection for Crohn's disease (CD), inflammatory lesions frequently recur on the anastomosis and/or on the neo-terminal ileum. AIM: To identify predictors of early post-operative endoscopic recurrence. METHODS: From September 2010 to September 2017, the REMIND group conducted a prospective nationwide study in nine French academic centres. Data were collected at the time of surgery and endoscopy, performed 6-12 months after surgery. Endoscopic recurrence was defined as a Rutgeerts score ≥i2. Baseline factors associated with endoscopic recurrence were searched by univariate and multivariate regression analysis. RESULTS: Two hundred and eighty-nine CD patients were included. Endoscopy within 1 year following surgery was performed in 225 (78%) patients (104M/121F). Mean age and disease duration were 35 (12.2) and 8.8 (8.9) years respectively. Seventy (32%) patients were active smokers at surgery. One hundred and forty-two (63%) patients received at least one anti-TNF therapy before surgery. After surgery, 40 (18%) patients received thiopurines and 66 (29%) received an anti-TNF agent. Endoscopic recurrence occurred in 107 (47%) patients. In multivariate analysis, male gender (OR = 2.48 [IC 95% 1.40-4.46]), active smoking at surgery (OR = 2.65 [IC 95% 1.44-4.97]) and previous resection (OR = 3.03 [IC 95% 1.36-7.12]) were associated with a higher risk of endoscopic recurrence. Inversely, post-operative anti-TNF treatment decreased the risk of endoscopic recurrence (OR = 0.50 [IC 95% 0.25-0.96]). CONCLUSIONS: Male gender, active smoking at surgery and previous intestinal resection are associated with a higher risk of endoscopic post-operative recurrence, while post-operative anti-TNF treatment is associated with a lower risk.
引用
- Auzolle C, Nancey S, Tran-Minh ML, et al. Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study. Aliment Pharmacol Ther. 2018. PMID: 30126030. doi:10.1111/apt.14944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。